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Abstract: PURPOSE OF REVIEW Visual snow is considered a disorder of central visual processing
resulting in a perturbed perception of constant bilateral whole-visual field flickering or pixelation. When
associated with additional visual symptoms, it is referred to as visual snow syndrome. Its pathophysiology
remains elusive. This review highlights the visual snow literature focusing on recent clinical studies that
add to our understanding of its clinical picture, pathophysiology, and treatment. RECENT FINDINGS
Clinical characterization of visual snow syndrome is evolving, including a suggested modification of di-
agnostic criteria. Regarding pathophysiology, two recent studies tested the hypothesis of dysfunctional
visual processing and occipital cortex hyperexcitability using electrophysiology. Likewise, advanced func-
tional imaging shows promise to allow further insights into disease mechanisms. A retrospective study
now provides Class IV evidence for a possible benefit of lamotrigine in a minority of patients. SUMMARY
Scientific understanding of visual snow syndrome is growing. Major challenges remain the subjective na-
ture of the disease, its overlap with migraine, and the lack of quantifiable outcome measures, which are
necessary for clinical trials. In that context, refined perceptual assessment, objective electrophysiological
parameters, as well as advanced functional brain imaging studies, are promising tools in the pipeline.
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Purpose of review
Visual snow is considered a disorder of central visual processing resulting in a perturbed perception of
constant bilateral whole-visual field flickering or pixelation. When associated with additional visual
symptoms, it is referred to as visual snow syndrome. Its pathophysiology remains elusive. This review
highlights the visual snow literature focusing on recent clinical studies that add to our understanding of its
clinical picture, pathophysiology, and treatment.
Recent findings
Clinical characterization of visual snow syndrome is evolving, including a suggested modification of
diagnostic criteria. Regarding pathophysiology, two recent studies tested the hypothesis of dysfunctional
visual processing and occipital cortex hyperexcitability using electrophysiology. Likewise, advanced
functional imaging shows promise to allow further insights into disease mechanisms. A retrospective study
now provides Class IV evidence for a possible benefit of lamotrigine in a minority of patients.
Summary
Scientific understanding of visual snow syndrome is growing. Major challenges remain the subjective
nature of the disease, its overlap with migraine, and the lack of quantifiable outcome measures, which are
necessary for clinical trials. In that context, refined perceptual assessment, objective electrophysiological
parameters, as well as advanced functional brain imaging studies, are promising tools in the pipeline.
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INTRODUCTION
Since the first description of visual snow in the
literature in 1995 [1], visual snow syndrome has
emerged as a distinct clinical entity [2
&&
]. The hall-
mark of disease is the perception of constant bilat-
eral whole-visual field flickering or pixelation,
affecting the patients’ daily life. Visual snow syn-
drome is defined as visual snow with at least two
additional visual symptoms as outlined below.
Symptom onset ranges from childhood [3,4] to
elderly patients [5], but is usually reported in young
adulthood, equally affectingmen andwomen [6,7
&
].
There is an ongoing debate as to whether visual
snow syndrome should be considered as an organic
disease or rather as a heightened perception of
normal sensory phenomena [8]. However, the sur-
prising stereotypy of patients describing their symp-
toms, even in the absence of previous knowledge
about this condition, speaks against it being psycho-
genic in nature. Visual snow syndrome, by defini-
tion, is a benign condition and should not be
associated with signs of a progressive ophthalmic
or neurological disease. On rare occasions, however,
visual snow symptoms have also been described in
patients with serious neurological diseases such as
Creutzfeldt-Jakob disease [9] or glycine receptor
antibody syndrome [10]. The latter again seems to
underpin a probable organic basis and emphasizes
that careful adherence to diagnostic criteria, partic-
ularly the exclusion of other ophthalmic or neuro-
logic disease, is essential.
Early studies have focused on clinical character-
ization of visual snow syndrome [11–14]. The
pathophysiology, however, remains still unclear,
which goes hand in hand with the lack of effective
treatment strategies. This review follows up on a
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comprehensive review article about visual snow
syndrome by Puledda et al. [2
&&
] published in
February 2018 in this journal. Our article highlights
the most recent literature on visual snow syndrome
with a focus on the clinical studies that add to our
understanding and management of the condition.
The objective of this review is to condense our
current appreciation of the clinical picture, of the
pathophysiology and available treatments.
We did a systematic literature search on PubMed
up to August 2019 for articles on visual snow
with the keywords ‘visual snow’ ‘visual snow




Based on their first systematic characterization of
visual snow patients, preliminary criteria for visual
snow syndrome were elaborated by Schankin et al.
[11] and later suggested as definite clinical criteria
[2
&&
]. These consist of
(1) Visual snow lasting longer than 3 months: per-
ceived as dynamic, continuous, tiny dots in the
entire visual field.
(2) At least two additional visual symptoms of the
following four categories:
(a) Palinopsia: afterimages or trailing of mov-
ing objects.
(b) Enhanced entoptic phenomena (modifica-
tion suggested by Metzler and Robertson
[15
&
]: ‘other frequent or persistent visual
phenomena’): excessive floaters in both
eyes, excessive blue field entoptic phenom-




(3) Symptoms are not consistent with typical
migraine visual aura.
(4) Symptoms are not better explained by another
disorder.
Metzler and Robertson [15
&
] recently challenged
these criteria, namely section B (ii) ‘enhanced
entoptic phenomena’ based on the fact that they
had difficulty applying this section in the clinic.
Instead, they proposed B (ii) to be labelled ‘other
frequent or persistent visual phenomena’ arguing
that ‘entoptic phenomena’ are generally considered
to be phenomena arising from structures within the
eye. Apart from the fact that photopsias do not
necessarily originate from within the eye [16], the
proposed mild modification of the visual snow syn-
drome criteria would allow accounting for otherwise
unclassifiable phenomena described by some
patients with visual snow. The latter include ‘halos
around light-sources’, ‘geometric and coloured
images that distort vision’, ‘metamorphopsias’,
‘straight lines moving across the visual field’, ‘water
running down a window’, and ‘coloured clouds
when closing eyes’ [11].
Irrespective of this semantic debate, visual snow
syndrome criteria base on purely subjective descrip-
tions of visual symptoms. Ophthalmic and neuro-
logical examination is typically normal [11],
including perimetry [5,12,13,17], optical coherence
tomography [17], electroretinography [11–13,17] as
well as – until recently – visual evoked potentials
(VEP) [11–13,17].
On brain imaging, left occipital bending has
been mentioned in 4/14 patients [18
&&
]. Two studies
found this structural peculiarity to bemore frequent
in patients with major depressive disorders (35.3 vs.
12.3%) and with bipolar disorders (35.3 vs. 8.3%)
compared with healthy controls. However, the clin-
ical significance of this finding in patients with
visual snow is unclear. Otherwise, structural MRI
findings are typically reported normal [12,13].
Commonly associated nonvisual symptoms are
comorbid migraine, tinnitus, impaired concentra-





]. Migraine clearly is the
major confounding factor and thus challenges
visual snow research. It is not only a very common
KEY POINTS
 Thorough clinical characterization of visual snow
syndrome has led to its recognition as a clinical entity.
 The pathophysiology remains elusive; however,
bilateral pan-visual field involvement, frequently
associated palinopsia, abnormal suprathreshold
processing of contrast and luminance,
electrophysiological findings as well as functional brain
imaging point towards dysfunctional central
visual processing.
 Major challenges remain the purely subjective nature of
visual snow syndrome, its overlap with migraine, and
most importantly, the lack of quantifiable outcome
measures, which are prerequisite to design prospective
clinical trials.
 Based on a retrospective chart review, there is Class IV
evidence that a minority of patients may profit from a
trial of lamotrigine.
 The majority of patients copes well with reassurance
about the benign nature of visual snow syndrome.
Neuro-ophthalmology
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comorbid disease (up to 58% of visual snow
patients) [13,14,19
&&
], but probably also shares com-
mon disease mechanisms with visual snow [11,14],





Visual snow syndrome is generally considered to









]. However, its cause remains
largely unknown.
Lauschke et al. [13] tested colourimetry in 12
visual snow patients and found the yellow-blue
colour spectrum to provide relief of symptoms in
10/12 patients. Thus, they consider visual snow to
be a disorder of central colour-dependent processing
involving themagnocellular pathway and suggested
thalamocortical dysrhythmia as a possible underly-
ing mechanism. The latter disease concept has been
mostly discussed in the context of neurogenic pain,
tinnitus, Parkinson’s disease, and depression [20–
22]. While being an interesting hypothesis, studies
actually measuring thalamocortical dysrhythmia in
visual snow patients are regrettably still missing.
Chen et al. [23] mentioned cortical hyperexcit-
ability as a possible pathophysiological mechanism
based on a magnetoencephalography study involv-
ing six patients with ‘persistent visual aura’, two of
which had visual snow.
More recently, the concept of cortical hyperex-
citability was supported in a behavioural study by
McKendrick et al. [24]. Consistent with elevated
spontaneous neural firing in the primary visual
cortex, they found abnormal suprathreshold
processing of contrast (centre-surround contrast
matching) and luminance (luminance increment
detection in noise) in 16 visual snow patients com-
pared with 18 controls. However, no differences
were found for global form andmotion tasks, which
are attributed to extrastriate processing. If con-
firmed in larger studies, measurement of perceptual
differences in visual snow may hold potential for
diagnostic clinical tests and monitoring of treat-
ment effects in the future.
Eren et al. [25
&&
] tested the hypothesis of dys-
functional visual processing using pattern-reversal
VEP in 18 affected patients compared with 18
migraineurs and 18 healthy controls. On a group
level, they found a trend for reduced N75-P100
amplitudes in visual snow patients and a mildly,
but significantly increased N145 latency compared
with healthy controls independent of comorbid
migraine. The fusiform gyrus is the supposed origin
of the late phase P100 [26] and is adjacent to
the lingual gyrus. Arguing that late phase P100
represents the transition to N145, – which was
prolonged in the study – the authors claim to pos-
sibly show the first electrophysiological correlate to
the reported hypermetabolism of the lingual gyrus
[14]. While the line of argument regarding localiza-
tion seems rather long-winded, the findings of Eren
et al. might still further support the idea of visual
snow as a disorder involving extrastriate cortical
areas [25
&&
]. Of note, latencies of N75 and P100
did not differ between visual snow and controls,
making dysfunction of the early cortical visual proc-
essing unlikely. In addition, there was no statisti-
cally significant difference of N75-P100 amplitude
habituation to repetitive VEP stimulation (six con-
secutive blocks of 75 responses) between groups.
Based on related previous case reports [27,28],
Yildiz et al. [18
&&
] prospectively investigated occipi-
tal cortex hyperexcitability by measuring the habit-
uation response to repetitive pattern-reversal VEP
consisting of 10 blocks of 100 averaged responses.
Ten visual snow patients withmigraine (VSm), seven
visual snow patients without migraine (VSwom), and
12 healthy controls were recruited. They measured
the N75-P100 VEP amplitude ratios of the 10th/1st
block of the right and left eye. Contrary to the results
of Eren et al., this study found a loss of the habitua-
tion response in VSm and VSwom compared with the
expected habituation in healthy controls. There was
no statistically significant difference between VSm
and VSwom, meaning that presence or absence
of migraine did not influence the habituation
response. Lack of habituation has been considered
a neurophysiological hallmark of interictalmigraine.
However, the latter has been put into question
recently [29]. Unfortunately, the study by Yildiz
et al. [18
&&
] did not include a pure migraine control
groupwithout visual snow. The authors also assessed
transcranial magnetic stimulation phosphene detec-
tion and found a lower left phosphene threshold in
patients with visual snow. In the post-hoc analysis,
the latter difference only reached statistical signifi-
cance in VSm compared with healthy controls. In
sum, Yildiz et al. propose loss of VEP habituation
and decreased phosphene threshold as possible
surrogate markers indicating occipital cortex hyper-
excitability.
It is understood that objective electrophysiolog-
ical parameters would be extremely useful to assay
benefits of treatment in visual snow. At present,





] which might, how-
ever, partly be related to different examination pro-
tocols, for example, when assessing habituation.
Larger studies are awaited to elucidate the field.
Functional brain imaging studies seem most
appropriate to find evidence for dysfunctional
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central visual processing. Apart from the occasional
occipital bending mentioned above, brain imaging
studies usually do not show specific structural abnor-
malities [11–13]. Jager et al. [30] investigated cere-
bral water diffusion and perfusion on MRI and
found no regional functional changes in his two
patients with visual snow. Schankin et al. [14] inves-
tigated seventeen patients with visual snow using
[(18) F]-2-fluoro-2-deoxy-D-glucose PET and found
hypermetabolism of the right lingual gyrus and left
anterior cerebellar lobe. This finding is consistent
with a disorder allocated downstream of the primary
visual cortex.
To further investigate abnormal central visual
processing, we are currently analysing resting state
functional MRI (fMRI) of patients with visual snow
compared with healthy controls within, but also
outside of the visual cortex. Preliminary data in
ten patients with visual snow and ten healthy con-
trols was presented at the 45th North-American
Neuro-Ophthalmology Society Meeting in Las
Vegas, USA, in March 2019 (https://www.nanoswe-
b.org/files/Annual%20Meeting’/2019/FINAL%20-
NANOS%20Brochure%20low%20res.pdf). Our
results point towards functional hyperconnectivity
in brain areas involved in form and motion process-
ing, as well as in areas associated with attention and
working memory. These findings suggest, that
visual snow patients not only have a metabolically
altered early visual cortex (lingual gyrus) [31], but
also show functional abnormalities in brain areas
associated with the accompanying symptoms of
visual snow, such as palinopsia (unpublished data).
In an attempt to explain why visual snow is
frequently associated with additional symptoms,
Metzler and Robertson [15
&
] discussed the concept
of stochastic resonance, a nonlinear phenomenon
where additional noise can improve the signal-to-
noise ratio, thus lowering the detection threshold of
another weak stimulus. The latter has not only been
shown for stimuli involving the same sensory
modality (e.g., vision) [32], but also for stimuli
involving different senses (e.g., vision and hearing)
[33]. The authors concluded that in a model of
stochastic resonance, visual snow might, for exam-
ple, enhance tinnitus or vice versa.
Patient management and treatment
Sharing our knowledge on visual snow and reassur-
ing the patient about the benign nature of the
condition often provides instant relief to the
patient. Nevertheless, a minority of patients may
request empiric treatment. Until recently, pharma-
cologic treatment was only based on case reports,
small case series, or expert opinion [2
&&
,6,28,34].
Recently, van Dongen et al. [19
&&
] evaluated treat-
ment options in a retrospective case series of 58
visual snow patients, out of which 47 patients had
visual snow syndrome. Given the lack of evidence,
29 patients chose no drug treatment. None of
the remaining treated patients experienced com-
plete remission under medication. Lamotrigine
(250mg) was prescribed most frequently
(n¼26) with partial remission of symptoms in 5/
26 (19.2%). However, adverse events were reported
in half of the patients (13/26) patients, including
allergic reactions (n¼3) and excessive daytime
sleepiness (n¼1). Eventually, only 4/26 patients
continued lamotrigine treatment. One patient
improved under topiramate (n¼4), but still stopped
the medication because of side effects. Valproate
(n¼7), acetazolamide (n¼2) and flunarizine
(n¼1) did not improve symptoms in this case series.
Overall, evidence for pharmacological treatment in
visual snow remains scarce (Class IV evidence).
Thus, treatment should be limited to selected
patients only.
Treatment of comorbid diseases like migraine or
mood disorders is certainly worth considering
depending on the severity. However, there is no
evidence suggesting benefit with regard to visual
snow symptoms.
Recently, real-time fMRI neurofeedback has
been proposed as a potential intervention for several
neurological and psychiatric disorders [35–41]. As
there is hypermetabolism in the lingual gyrus and
growing evidence of dysfunctional connectivity in
the brain, single region real-time fMRI neurofeed-
back may be a promising intervention strategy to
normalize brain function in the future.
CONCLUSION
Research about visual snow syndrome has gone
through an early phase of thorough clinical charac-
terization leading to its recognition as a clinical
entity. Overall, the disease is most likely related to
dysfunctional central visual processing, which is
also supported by the most recent clinical studies.
Our scientific understanding of visual snow syn-
drome has started to grow as we now put bits and
pieces of the puzzle together. However, major chal-
lenges remain, such as the purely subjective nature
of visual snow syndrome, its overlap with migraine,
and most importantly the lack of quantifiable and
reliable outcome measures, which are prerequisite
to design prospective clinical trials. In that context,
measurement of refined perceptual differences,
objective electrophysiological parameters, as well
as advanced functional brain imaging studies
including real-time fMRI neurofeedback, may hold
Neuro-ophthalmology
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potential but need further investigations on a larger
scale. In the meantime, we are left with Class IV
evidence that a minority of patients may profit from
a trial of oral lamotrigine and with the confidence
that most patients cope very well with reassurance.
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